Gampenrieder, S., Dezentjé, V., Lambertini, M., de Nonneville, A., Marhold, M., Le Du, F., . . . Greil, R. (2022). Influence of HER2 expression on prognosis in metastatic triple-negative breast cancer—results from an international, multicenter analysis coordinated by the AGMT Study Group.
Chicago Style CitationGampenrieder, SP, et al. Influence of HER2 Expression On Prognosis in Metastatic Triple-negative Breast Cancer—results From an International, Multicenter Analysis Coordinated By the AGMT Study Group. 2022.
MLA CitationGampenrieder, SP, et al. Influence of HER2 Expression On Prognosis in Metastatic Triple-negative Breast Cancer—results From an International, Multicenter Analysis Coordinated By the AGMT Study Group. 2022.
Note: citation formatting may not correspond 100% to that defined by the respective standard, to manage citations it is recommended to use the software Zotero
, which allows the automatic upload of Oasisbr references.